68,624 research outputs found
Detection of HBV Genotypes of Tumor Tissues and Serum by A Fluorescence Polarization Assay in North-Western China's Hepatocellular Carcinoma Patients
<p>Abstract</p> <p>Background</p> <p>The understanding of the distribution of hepatitis B virus genotypes and the occult hepatitis B virus infection in hepatocellular carcinoma may shed light into the prevention and treatment of hepatocellular carcinoma. The purpose of the study is to investigate hepatitis B virus genotypes distribution, the high-risk genotypes and the occult infection in north-western China's hepatocellular carcinoma patients.</p> <p>Methods</p> <p>Hepatitis B virus genotypes A-D of hepatocellular carcinoma tumor tissues and serum samples in 268 north-western China hepatocellular carcinoma patients were detected by fluorescence polarization assay. The hepatitis B virus genotypes in serum and matched primary tumor tissue samples were compared. Hepatitis B surface antigen and α-fetoprotein in serum were detected. Occult hepatitis B virus infections were analyzed. The relationship between hepatitis B virus genotypes and clinicopathologic characteristics were analyzed statistically using SPSS v.10.0.</p> <p>Results</p> <p>Intrahepatic hepatitis B virus DNA was detected in 83.6% of 268 patients, whereas serum hepatitis B virus DNA was detected in 78.7%. The hepatitis B virus genotypes in serum were consistent with the results in matched tumor tissue. Intrahepatic hepatitis B virus genotype B and C were detected respectively in 11.6% and 54.5% of the patients. Mixed intrahepatic hepatitis B virus genotypes were detected in 13.4% of 268 patients. There was not mixed hepatitis B virus infection in Edmondonson grade I. The patients with mixed HBV genotypes exhibited statistically significant different Edmondson grade than the patients with single type HBV infection (p < 0.05). Hepatitis B surface antigens were positive in 77.2% of 268 patients. Hepatitis B virus genotype C was detected in 64.7% of occult infected patients. There was no significant differences of patients' ages and α-fetoprotein level in different groups of intrahepatic hepatitis B virus genotypes (p > 0.05).</p> <p>Conclusions</p> <p>Hepatitis B virus genotype C was associated closely with the development of hepatocellular carcinoma and the occult hepatitis B virus infection in patients in north-western China. There was a relatively high prevalence of mixed hepatitis B virus infection in Edmondonson grade III-IV.</p
The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: A population-based study
Background: Hepatitis B virus infection is a very common cause of chronic liver disease worldwide. It is estimated that 3 of Iranians are chronically infected with hepatitis B virus. Current population-based studies on both rural and urban prevalence of hepatitis B virus infection in Iran are sparse with results that do not always agree. We performed this study to find the prevalence of hepatitis B surface antigen, anti-hepatitis B core antibody, and associated factors in the general population of three provinces of Iran. Methods: We randomly selected 6,583 subjects from three provinces in Iran, namely Tehran, Golestan, and Hormozgan. The subjects were aged between 18 and 65 years. Serum samples were tested for hepatitis B surface antigen and anti-hepatitis B core antibody. Various risk factors were recorded and multivariate analysis was performed. Results: The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran was 2.6 and 16.4, respectively. Predictors of hepatitis B surface antigen or anti-hepatitis B core antibody in multivariate analysis included older age, not having high-school diploma, living in a rural area, and liver disease in a family member. We did not find any significant differences between males and females. Conclusion: In spite of nationwide vaccination of newborns against hepatitis B virus since 1992, hepatitis B virus infection remains a very common cause of chronic liver disease in Iran which should be dealt with for at least the next 30-50 years
Prevention of Hepatitis B Virus Transmission in Pregnancy
Chronic hepatitis B virus infection is a serious health problem in many countries, particularly in developing countries. In Asia-Pacific region, vertical transmission from mother to child is the main endemicity factor of hepatitis B virus (HBV) infection. Almost 50% cases of hepatitis B virus infection happen during perinatal and neonatal period, including vertical transmission from mother to child during pregnancy.World Health Organization (WHO), World Gastroenterology Organization (WGO) and many countries have recommended immunoprophylaxis by the administration of hepatitis B vaccine and hepatitis B immunoglobulin (HBIg) to prevent transmission from mother to child. However, there are approximately 10-15% babies born from mother with hepatitis B infected by HBV through intrauterine transmission. Incidence of intrauterine transmission is accounted for around 43-50% if DNA of HBV in the mother is more than 107 copies/mL, although passive and active immunization to the baby has been administered. Therefore, administering antiviral drugs in pregnant women with chronic hepatitis B accompanied by immunoprophylaxis is effective in preventing hepatitis B infection transmission during pregnancy, particularly in decreasing the number of virus and administering active or even passive immunization to neonates
A homosexual japanese man with acute hepatitis due to hepatitis B virus genotype ae, concurrent with amebic colitis
We report herein a case with acute hepatitis due to hepatitis B virus genotype Ae, concurrent with
amebic colitis. A 39-year-old homosexual Japanese man was admitted to our hospital with jaundice.
Laboratory tests showed an elevation of transaminase and positivity for hepatitis B surface antigen and IgM-type antibody to hepatitis B core antigen. The hepatitis B virus genotype was determined to be Ae. Furthermore, a mud-like stool with blood and mucous had sometimes been noted during the
past 3 years, and amebic colitis was shown by colonofi berscopy during hospitalization. The patient was diagnosed with acute hepatitis B, concurrent with amebic colitis, and was successfully treated with lamivudine and metronidazole. In Japanese patients with acute hepatitis B virus genotype A infection, homosexual activity tends to be high. Furthermore, in Japanese homosexual men, amebiasis
has been increasing. Thus, in Japanese patients with acute hepatitis B, a determination of genotype should be performed in order to investigate the route of transmission of hepatitis B virus, and a search for amebiasis should be performed in patients with acute hepatitis due to hepatitis B virus genotype A. Furthermore, education of homosexual men regarding hepatitis B virus, hepatitis B
virus vaccination, and amebiasis is urgently required
Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study
Background Preterm birth is the leading cause of child death in children younger than 5 years. Large cohort studies in
developed countries have shown that maternal hepatitis B virus infection is associated with preterm birth, but there
is little reliable evidence from China and other developing countries, where hepatitis B virus prevalence is intermediate
or high. Hence, we designed this study to investigate the association between pre-pregnancy hepatitis B virus infection
and risk of preterm and early preterm birth.
Methods Between Jan 1, 2010, and Dec 31, 2012, we did a population-based cohort study using data from 489 965 rural
women aged 21–49 years who had singleton livebirths from 220 counties of China who participated in the National
Free Preconception Health Examination Project. Participants were divided into three groups according to their prepregnancy
status of hepatitis B virus infection: women uninfected with hepatitis B virus (control group), women who
were HBsAg positive and HBeAg negative (exposure group 1), and women who were both HBsAg and HBeAg positive
(exposure group 2). The primary outcome was preterm birth (gestation at less than 37 weeks). We used log-binomial
regression to estimate adjusted risk ratios (aRR) of preterm birth for women with pre-pregnancy hepatitis B virus
infection, and risk of early preterm birth (gestation less than 34 weeks).
Findings 489 965 women met inclusion criteria and were included in this study; of these, 20 827 (4·3%) were infected
with hepatitis B virus. Compared with women who were not infected with hepatitis B virus, women who were HBsAg
positive and HBeAg negative had a 26% higher risk of preterm birth (aRR 1·26, 95% CI 1·18–1·34) and women who
were both HBsAg and HBeAg positive had a 20% higher risk of preterm birth (aRR 1·20, 1·08–1·32). Compared with
women who were not infected with hepatitis B virus, women who were HBsAg positive and HBeAg negative
manifested an 18% higher risk of early preterm birth (gestation less than 34 weeks; aRR 1·18, 1·04–1·34) and women
who were both HBsAg and HBeAg positive had a 34% higher risk of early preterm birth (aRR 1·34, 1·10–1·61).
Maternal pre-pregnancy hepatitis B virus infection was independently associated with higher risk of preterm birth
and early preterm birth. These associations were similar in subgroups of participants as defined by baseline
characteristics.
Interpretation Besides mother-to-child transmission, the risk of preterm birth in women infected with hepatitis B
virus should not be neglected. Comprehensive programmes that focus on early detection of hepatitis B virus infection
before pregnancy and provide appropriate medical intervention for women infected with hepatitis B virus before and
during pregnancy would be helpful in improving maternal and neonatal outcomes and reducing child mortality
Hepatitis B Virus Double Mutations is There Any Role in Pathogenesis of Hepatocellular Carcinoma in Young Patients
Background: The incidence of hepatocellular carcinoma (HCC) below age 40 years old in our institution were relatively high compared with other institutions in Asia. Hepatitis B virus (HBV) basal core promoter (BCP) double mutations correspond with increasing age. The aim of this study was to know if there was any role of HBV double mutations in young HCC patients. Method: A descriptive study was performed on HBV related HCC patients in Cipto Mangunkusumo Hospital in May 2006-November 2008. Patient were recruited consecutively and divided in to two groups, below 40 and above 40 years old. The genotypes were examined by polymerase chain reaction (PCR) method. The alpha feto protein (AFP) values were diagnosed based on ELISA method. The BCP A1762T/G1764A double mutations were examined by direct sequencing. Results: There were 49 HBV related HCC samples consist of 14 (28.5%) samples with age below 40 years old and 35 (71.5%) samples with age above 40 years old. We only found two genotype, genotype B was dominant in patients with HBV related HCC compare to genotype C, 43 (88%) and 6 (12%) respectively. The increasing of AFP level above 400 ng/mL was only found in about half of the samples, 7 (50%) < 40 years old, 19 (54%) > 40 years old. Double mutations of A1762T/G1764A in BCP occurred in 5 (36%) < 40 years old, 15 (43%) > 40 years old. Conclusion: The incidence of HBV related HCC in young patients were relatively high. The proportion of patients with AFP level < 400 ng/mL in patients below 40 years old were higher compared to patients above 40 years
An appraisal of the prevention of mother-to-child transmission of hepatitis B virus health system in Nigeria
The study aimed to assess the strengths and weaknesses, opportunities and threats influencing the achievement of prevention of mother-to-child transmission of hepatitis B virus. It also sought to suggest recommendations to improve the current prevention of mother-to-child transmission of hepatitis B virus health system in Nigeria. A critical appraisal of the prevention of mother-to-child transmission of hepatitis B virus health system in Nigeria was conducted. The WHO health system framework was used to assess the prevention of mother-to-child transmission of hepatitis B virus system. Considering the recent call by the World Health Organization to eliminate hepatitis and the existence of a robust prevention of mother-to-child transmission of human immunodeficiency virus health system, the prevention of mother-to-child transmission of hepatitis B virus health system in Nigeria is riddled with numerous challenges. These range from a health worker crisis, poor leadership and governance, inadequate health information, medicines, vaccines and technologies and poor service delivery. Urgent action in the Nigerian prevention of mother-to-child transmission of hepatitis B virus health system is required if Nigeria is to achieve its goal of eliminating hepatitis by 2021
Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease
Fifty‐nine patients with prior hepatitis B virus infection underwent orthotopic liver transplantation. During the first 2 mo, mortality was not significantly different in the hepatitis B virus–infected group (25.5%) vs. a hepatitis B virus–immune control group (21%). Beyond 2 mo, the mortality, rate of graft loss, need for retransplantation and incidence of abnormal liver function were significantly higher in the hepatitis B virus–infected group. Treatment of the hepatitis B virus infection was attempted with passive immunization, combined active and passive immunization, α‐interferon or nothing. The clinical outcome was not significantly influenced by any of these therapies. However, of the patients who lived more than 60 days, 6 of 22 treated with active plus passive immunization were cleared of HBsAg, something achieved once in 16 patients treated with α‐interferon, never in 3 patients with passive immunization only and once in 4 patients with no therapy. In patients with recurrent hepatitis B virus infection, the pace of hepatitis development in the graft appeared to be accelerated, and this was particularly striking in patients who underwent multiple retransplantations at progressively shorter intervals. None of the patients who became HBsAg‐negative had HBeAg preoperatively. (HEPATOLOGY 1991;13:619–626.) Copyright © 1991 American Association for the Study of Liver Disease
Hepatitis B virus infection: Knowledge of antenatal attendees in a tertiary hospital
Background: Hepatitis B virus infection constitutes a significant global health problem, and perinatal transmission continues to be one of the major routes of transmission in Nigeria. Having adequate knowledge about the virus and the available prevention strategies may lead to behavioural changes that will reduce the rate of acquisition and transmission of the virus.
Objectives: To assess the knowledge about Hepatitis B virus infection among pregnant women attending antenatal booking clinic
Methods: This was a cross-sectional study involving 354 pregnant women who presented for antenatal booking at Olabisi Onabanjo University Teaching Hospital Sagamu, Ogun State, Nigeria from 1stMay to 31st July 2018. A pretested questionnaire was administered to assess awareness, knowledge and attitude of pregnant women to hepatitis B virus infection. Statistical analysis was done using IBM-SPSS version 21 (IBM Corp, Armonk, NY, USA).
Results: Two hundred and twenty-eight women (64.4%) were aware of Hepatitis B virus infection. One hundred and eightyseven women (52.8%) correctly identified hepatitis as a viral infection, while 173 (48.9%) knew that hepatitis B mainly affects the liver. The major source of information was health workers. More than half of the women could not correctly identify the mode of transmission and methods of prevention of hepatitis B virus infection. There was a significant association between age and educational status of the women, and knowledge of Hepatitis B virus infection (p=0.001, p=0.002 respectively).
Conclusion: This study demonstrates a knowledge deficit on Hepatitis B virus infection among pregnant women. We recommend that there should be a community-based health education strategy targeted at increasing the awareness and knowledge of hepatitis B virus infectio
- …